Ajanta Pharma Q4 Revenue Climbs to Rs 1,422 Cr, Profit Up 18%
New Delhi: Ajanta Pharma Ltd on Tuesday reported a 18.4 per cent rise in consolidated net profit at Rs 266.7 crore in the fourth quarter ended March 31, on the back of strong US generics revenue growth.
The company had posted a consolidated net profit of ₹225.26 crore in the corresponding period previous fiscal, Ajanta Pharma Ltd said in a regulatory filing.
Consolidated revenue from operations in the fourth quarter stood at ₹1,421.64 crore as against ₹1,170.41 crore in the year-ago period, it added.
During the quarter branded generics in the markets of India, Asia and Africa clocked a combined revenue of ₹859 crore as compared to ₹805 crore in the year-ago period, up 7 per cent.
US generic revenue was at ₹505 crore as compared to ₹325 crore in the same period a year ago, up 56 per cent, the company said.
Total expenses in the fourth quarter were higher at ₹1,135.96 crore as compared to ₹919.11 crore in the same period a year ago, the company said.
For FY26, consolidated net profit was at ₹1,056 crore as compared to ₹920.39 crore in FY25.
Consolidated revenue from operations in FY26 stood at ₹5,452.86 crore as compared to ₹4,648.1 crore in FY25, the company said.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.